practical application of recent clinical data for immunotherapy in nsclc
Published 5 years ago • 121 plays • Length 1:00:44Download video MP4
Download video MP3
Similar videos
-
1:02:36
practice changes for use of immunotherapy in nsclc
-
32:52
immunotherapy for early-stage, resectable nsclc: from clinical trial data to guidelines
-
1:35
dr. socinski on new applications of immunotherapy in nsclc
-
9:57
practical considerations for immunotherapy in stage 3 nsclc
-
8:37
new data for checkpoint inhibitors in nsclc
-
4:16
upfront pd-1 inhibitor monotherapy in advanced nsclc
-
5:25
immunotherapy in lung cancer
-
2:32
practical considerations for adjuvant vs. neoadjuvant immunotherapy in nsclc
-
5:31
practice changes for use of immunotherapy in nsclc: q&a
-
1:22
dr. bauml on the use of immunotherapy in oligometastatic nsclc
-
5:00
implications for pembrolizumab in nsclc
-
5:43
duration of upfront immunotherapy for nsclc
-
6:42
pseudoprogression with checkpoint inhibitors in non-small cell lung cancer
-
8:48
upfront use of immunotherapy for ncslc
-
7:01
actual use of pembrolizumab and chemotherapy in nsclc
-
22:06
basics of immunotherapy in nsclc
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
36:55
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
7:11
immunotherapy in the frontline and as part of combinations for nsclc